Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Barr Will Launch Generic Ovcon 35 In October After Regaining Rights To ANDA

This article was originally published in The Pink Sheet Daily

Executive Summary

Under pressure from FTC, Warner Chilcott ends an exclusive agreement which was blocking Barr entry until May 2009.

You may also be interested in...



FTC Enjoins Warner Chilcott From Providing “Anything Of Value” To ANDA Filers

Commission settles charges against the brand drug maker related to generic Ovcon 35.

FTC Enjoins Warner Chilcott From Providing “Anything Of Value” To ANDA Filers

Commission settles charges against the brand drug maker related to generic Ovcon 35.

Cephalon Provigil Generics Settlements Under FTC Investigation

FTC seeking information on four deals that postpone generic entry.

Topics

UsernamePublicRestriction

Register

PS064920

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel